InsiderTrades

Form 4 for COYA Coya Therapeutics, Inc.

Accepted 2023-01-04 00:00:00 ET · period of report 2022-01-03 · accession 0001493152-23-000226 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-01-04 2023-01-03 COYA Lee Ann Dir P - Purchase — +10.0K 10.0K New —
D 2023-01-04 2023-01-03 COYA Lee Ann Dir C - Cnv Deriv $4.00 +6,479 16.5K +65% +$25.9K
D 2023-01-04 2023-01-03 COYA Lee Ann Dir C - Cnv Deriv — 0 6,479 New —
D 2023-01-04 2023-01-03 COYA Lee Ann Dir P - Purchase — +5,000 9,479 +112% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 per share 2023-01-03 P A 10,000 — 10,000 D — — (F1) Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering ("IPO") at a combined purchase price $5.00 per share and accompanying warrant.
2 Common Common Stock, par value $0.0001 per share 2023-01-03 C A 6,479 $4.00 16,479 D — —
3 Derivative 6% Convertible Note 2023-01-03 C D — $0.00 6,479 D $4.00 · — to — 6,479 Common Stock, par value $0.0001 per share (F2) Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum.
4 Derivative Warrant to Purchase Common Stock 2023-01-03 P A 5,000 — 9,479 D $7.50 · 2023-01-03 to 2025-01-03 5,000 Common Stock, par value $0.0001 per share (F1) Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering ("IPO") at a combined purchase price $5.00 per share and accompanying warrant.